{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:30:37Z","timestamp":1784143837495,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH015"],"award-info":[{"award-number":["ZR2023MH015"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271878"],"award-info":[{"award-number":["82271878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02129-x","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T01:53:53Z","timestamp":1763690033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel insights into the effect of sTIM-3 on NLRP3 inflammasome via interacting with ASC"],"prefix":"10.1007","volume":"74","author":[{"given":"Xiaodi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanchang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2129_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314905","author":"B Oronsky","year":"2022","unstructured":"Oronsky B, Caroen S, Reid T. What exactly is inflammation (and what is it not?). Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232314905.","journal-title":"Int J Mol Sci"},{"key":"2129_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","author":"N Kelley","year":"2019","unstructured":"Kelley N, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20133328.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2129_CR3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu J, Nunez G. The NLRP3 inflammasome: activation and regulation. Trends Biochem Sci. 2023;48(4):331\u201344.","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"2129_CR4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/brain\/awaa135","volume":"143","author":"A Kadowaki","year":"2020","unstructured":"Kadowaki A, Quintana FJ. The NLRP3 inflammasome in progressive multiple sclerosis. Brain. 2020;143(5):1286\u20138.","journal-title":"Brain"},{"key":"2129_CR5","doi-asserted-by":"crossref","first-page":"109697","DOI":"10.1016\/j.intimp.2023.109697","volume":"115","author":"W He","year":"2023","unstructured":"He W, et al. The role of NLRP3 inflammasome in sepsis: a potential therapeutic target. Int Immunopharmacol. 2023;115:109697.","journal-title":"Int Immunopharmacol"},{"issue":"7865","key":"2129_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon KO, et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature. 2021;595(7865):101\u20136.","journal-title":"Nature"},{"issue":"11","key":"2129_CR7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni988","volume":"4","author":"CA Sabatos","year":"2003","unstructured":"Sabatos CA, et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol. 2003;4(11):1102\u201310.","journal-title":"Nat Immunol"},{"issue":"93","key":"2129_CR8","doi-asserted-by":"crossref","first-page":"eadf2223","DOI":"10.1126\/sciimmunol.adf2223","volume":"9","author":"KO Dixon","year":"2024","unstructured":"Dixon KO, Lahore GF, Kuchroo VK. Beyond T cell exhaustion: TIM-3 regulation of myeloid cells. Sci Immunol. 2024;9(93):eadf2223.","journal-title":"Sci Immunol"},{"issue":"6","key":"2129_CR9","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1084\/jem.20062093","volume":"204","author":"J Kearley","year":"2007","unstructured":"Kearley J, McMillan SJ, Lloyd CM. Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo. J Exp Med. 2007;204(6):1289\u201394.","journal-title":"J Exp Med"},{"issue":"7","key":"2129_CR10","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.4049\/jimmunol.180.7.4409","volume":"180","author":"L Yang","year":"2008","unstructured":"Yang L, et al. Lack of TIM-3 immunoregulation in multiple sclerosis. J Immunol. 2008;180(7):4409\u201314.","journal-title":"J Immunol"},{"issue":"5","key":"2129_CR11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/03009742.2010.547871","volume":"40","author":"J Lee","year":"2011","unstructured":"Lee J, et al. Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis. Scand J Rheumatol. 2011;40(5):334\u201340.","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"2129_CR12","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207(10):2187\u201394.","journal-title":"J Exp Med"},{"issue":"1","key":"2129_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imm.12812","volume":"153","author":"W Wang","year":"2018","unstructured":"Wang W, et al. Negative regulation of Nod-like receptor protein 3 inflammasome activation by T cell Ig mucin-3 protects against peritonitis. Immunology. 2018;153(1):71\u201383.","journal-title":"Immunology"},{"issue":"2","key":"2129_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbamcr.2013.11.014","volume":"1843","author":"O Schweigert","year":"2014","unstructured":"Schweigert O, et al. Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by a disintegrin and metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine. Biochim Biophys Acta. 2014;1843(2):275\u201387.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"2129_CR15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbmt.2013.06.011","volume":"19","author":"JA Hansen","year":"2013","unstructured":"Hansen JA, et al. A novel soluble form of Tim-3 associated with severe graft-versus-host disease. Biol Blood Marrow Transplant. 2013;19(9):1323\u201330.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2129_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/tan.12653","volume":"86","author":"F Ren","year":"2015","unstructured":"Ren F, et al. Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes. Tissue Antigens. 2015;86(5):325\u201332.","journal-title":"Tissue Antigens"},{"issue":"1","key":"2129_CR17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2020.09.007","volume":"147","author":"T Ueland","year":"2021","unstructured":"Ueland T, et al. Elevated plasma sTIM-3 levels in patients with severe COVID-19. J Allergy Clin Immunol. 2021;147(1):92\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2129_CR18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/08916934.2021.1891535","volume":"54","author":"D Zhao","year":"2021","unstructured":"Zhao D, et al. Elevated soluble Tim-3 correlates with disease activity of systemic lupus erythematosus. Autoimmunity. 2021;54(2):97\u2013103.","journal-title":"Autoimmunity"},{"key":"2129_CR19","doi-asserted-by":"crossref","first-page":"115445","DOI":"10.1016\/j.bcp.2023.115445","volume":"209","author":"C Bailly","year":"2023","unstructured":"Bailly C, et al. Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases. Biochem Pharmacol. 2023;209:115445.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"2129_CR20","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1016\/j.cell.2024.07.016","volume":"187","author":"LP Andrews","year":"2024","unstructured":"Andrews LP, et al. LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-gamma-dependent anti-tumor immunity. Cell. 2024;187(16):4355-4372.e22.","journal-title":"Cell"},{"issue":"16","key":"2129_CR21","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1016\/j.cell.2024.06.036","volume":"187","author":"AR Cillo","year":"2024","unstructured":"Cillo AR, et al. Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity. Cell. 2024;187(16):4373-4388.e15.","journal-title":"Cell"},{"issue":"16","key":"2129_CR22","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1016\/j.cell.2024.07.018","volume":"187","author":"SF Ngiow","year":"2024","unstructured":"Ngiow SF, et al. LAG-3 sustains TOX expression and regulates the CD94\/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity. Cell. 2024;187(16):4336-4354.e19.","journal-title":"Cell"},{"issue":"4","key":"2129_CR23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1084\/jem.20180870","volume":"216","author":"B Gong","year":"2019","unstructured":"Gong B, et al. Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer. J Exp Med. 2019;216(4):982\u20131000.","journal-title":"J Exp Med"},{"issue":"6","key":"2129_CR24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41416-023-02558-7","volume":"130","author":"J Gorgulho","year":"2024","unstructured":"Gorgulho J, et al. Soluble lymphocyte activation gene-3 (sLAG3) and CD4\/CD8 ratio dynamics as predictive biomarkers in patients undergoing immune checkpoint blockade for solid malignancies. Br J Cancer. 2024;130(6):1013\u201322.","journal-title":"Br J Cancer"},{"key":"2129_CR25","doi-asserted-by":"crossref","first-page":"27528","DOI":"10.1038\/srep27528","volume":"6","author":"C Xie","year":"2016","unstructured":"Xie C, et al. Soluble B7\u2013H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4\/NF-kappaB pathway. Sci Rep. 2016;6:27528.","journal-title":"Sci Rep"},{"issue":"5","key":"2129_CR26","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.4049\/jimmunol.1202777","volume":"191","author":"ST Haile","year":"2013","unstructured":"Haile ST, et al. Soluble CD80 restores T cell activation and overcomes tumor cell programmed death ligand 1-mediated immune suppression. J Immunol. 2013;191(5):2829\u201336.","journal-title":"J Immunol"},{"issue":"8","key":"2129_CR27","doi-asserted-by":"crossref","first-page":"101686","DOI":"10.1016\/j.xcrm.2024.101686","volume":"5","author":"C Chen","year":"2024","unstructured":"Chen C, et al. Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance. Cell Rep Med. 2024;5(8):101686.","journal-title":"Cell Rep Med"},{"key":"2129_CR28","doi-asserted-by":"crossref","first-page":"770402","DOI":"10.3389\/fimmu.2021.770402","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang L, et al. Tim-3 relieves experimental autoimmune encephalomyelitis by suppressing MHC-II. Front Immunol. 2021;12:770402.","journal-title":"Front Immunol"},{"key":"2129_CR29","doi-asserted-by":"crossref","first-page":"685139","DOI":"10.3389\/fimmu.2021.685139","volume":"12","author":"C Picon","year":"2021","unstructured":"Picon C, et al. Identification of the immunological changes appearing in the CSF during the early immunosenescence process occurring in multiple sclerosis. Front Immunol. 2021;12:685139.","journal-title":"Front Immunol"},{"issue":"2","key":"2129_CR30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","volume":"348","author":"RS Hotchkiss","year":"2003","unstructured":"Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138\u201350.","journal-title":"N Engl J Med"},{"key":"2129_CR31","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1038\/ncomms11929","volume":"7","author":"MS Dick","year":"2016","unstructured":"Dick MS, et al. ASC filament formation serves as a signal amplification mechanism for inflammasomes. Nat Commun. 2016;7:11929.","journal-title":"Nat Commun"},{"issue":"6","key":"2129_CR32","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","volume":"156","author":"A Lu","year":"2014","unstructured":"Lu A, et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell. 2014;156(6):1193\u2013206.","journal-title":"Cell"},{"issue":"3","key":"2129_CR33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20172222","volume":"215","author":"D Boucher","year":"2018","unstructured":"Boucher D, et al. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J Exp Med. 2018;215(3):827\u201340.","journal-title":"J Exp Med"},{"issue":"8","key":"2129_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","volume":"18","author":"BS Franklin","year":"2014","unstructured":"Franklin BS et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat Immunol, 2014;15(8):727\u201337. https:\/\/doi.org\/10.1038\/ni.2913","journal-title":"Nat Immunol"},{"issue":"8","key":"2129_CR35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2129_CR36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell. 2015;27(4):450\u201361.","journal-title":"Cancer Cell"},{"issue":"1","key":"2129_CR37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-020-00308-2","volume":"5","author":"Y Kong","year":"2020","unstructured":"Kong Y, et al. Storm of soluble immune checkpoints associated with disease severity of COVID-19. Signal Transduct Target Ther. 2020;5(1):192.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2129_CR38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40364-024-00647-0","volume":"12","author":"L Chen","year":"2024","unstructured":"Chen L, et al. Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications. Biomark Res. 2024;12(1):95.","journal-title":"Biomark Res"},{"issue":"4","key":"2129_CR39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12(4):252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"2129_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu J, Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation. Annu Rev Immunol. 2023;41:301\u201316.","journal-title":"Annu Rev Immunol"},{"key":"2129_CR41","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210998","author":"SZ Lu","year":"2022","unstructured":"Lu SZ, et al. Inhibition of astrocytic DRD2 suppresses CNS inflammation in an animal model of multiple sclerosis. J Exp Med. 2022. https:\/\/doi.org\/10.1084\/jem.20210998.","journal-title":"J Exp Med"},{"issue":"4","key":"2129_CR42","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","volume":"49","author":"M Deng","year":"2018","unstructured":"Deng M, et al. The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity. 2018;49(4):740-753.e7.","journal-title":"Immunity"},{"issue":"11","key":"2129_CR43","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","volume":"16","author":"X Du","year":"2019","unstructured":"Du X, et al. Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice. Cell Mol Immunol. 2019;16(11):878\u201386.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2129_CR44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-19-2332","volume":"80","author":"S Tan","year":"2020","unstructured":"Tan S, et al. Tim-3 hampers tumor surveillance of liver-resident and conventional NK cells by disrupting PI3K signaling. Cancer Res. 2020;80(5):1130\u201342.","journal-title":"Cancer Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02129-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02129-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:18Z","timestamp":1767199998000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02129-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2129"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02129-x","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Second Hospital of Shandong University (approval no. KYLL-2022-325). We certify that the study was performed in accordance with the 1964 declaration of HELSlNKl and later amendments. Written informed consent was obtained from all the participants prior to the enrollment of this study. This study and included experimental procedures were approved by the institutional animal care and use committee of Shandong university (approval no. ECSBMSSDU2022-2-37).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"169"}}